Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ATP2B2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ATP2B2 mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of ATP2B2 mRNA | decreases expression | 12958071
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP2B2 mRNA | affects cotreatment|decreases expression | 18164116
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP2B2 mRNA | affects cotreatment|decreases expression | 18164116
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of ATP2B2 mRNA | decreases expression | 15834898 17351261 17557909
|
C098607 |
JP8 aviation fuel |
JP8 aviation fuel affects the expression of ATP2B2 mRNA | affects expression | 12539871
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of ATP2B2 mRNA | decreases expression | 12057914
|
D010126 |
Ozone |
Ozone results in decreased expression of ATP2B2 mRNA | decreases expression | 16330353
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATP2B2 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ATP2B2 mRNA | increases expression | 19482888
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ATP2B2 mRNA | decreases expression | 19490992
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.95 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.95 | 11752688 14514962 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.16 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.18 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.84 | 14692618 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
7.14 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.14 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
18.53 | 17162532 19061943 18056438 19052882 16434500 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.53 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.53 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.46 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.64 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.74 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.58 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.67 | 17854713 16373670 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.18 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.95 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.95 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.79 | 15516495 18417511 16777450 17626835 18315731 19059883 14754758 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.93 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.74 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.74 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.74 | 16540662 20214788 20007298 20512989 21159647 19919837 18785209 20514400 18978308 19418558 20084675 18056438 3581430 20101231 19394651 16569478 19335982 18971187 19519916 16328049 16779866 16878318 16698587 10672840 16830150 18788625 19822196 18494052 16807293 16681979 20935162 19208518 18210153 20432363 19052882 19107877 3084413 20727157 19539802 18691550 19171122 17055752 16288022 16502159 20524982 17761372 19701751 17162532 17138121 18665156 17173139 19383236 17428255 10737359 18506893 18393292 17978847 16935385 11831363 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
6.74 | 1701930 6705139 20007298 17173139 20935162 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.01 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.01 | 2727394 17174075 7505956 21159647 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.43 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.74 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.74 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.98 | 17681005 16919318 11677210 16105132 17333356 17110522 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 16354765 12621046 8697196 15668235 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 15322242 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.49 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.49 | 18551238 |
OMIM:601386 |
DEAFNESS, AUTOSOMAL RECESSIVE 12 |
marker/mechanism |
|
| |
MESH:D017453 |
Dermatitis, Irritant |
|
JP8 aviation fuel |
7.34 | 17574719 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.32 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.32 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.28 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.28 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.28 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.28 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.15 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.35 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.59 | 17637181 15821434 15328337 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.28 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.09 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.95 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.67 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.43 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.21 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.33 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.17 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.17 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.14 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.12 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.40 | 10048152 11294989 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.52 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
9.03 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.03 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.98 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.61 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.57 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.74 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
8.74 | 12878042 9205823 17255318 17237260 17963957 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.74 | 12878042 12200463 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.78 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.76 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.76 | 16705839 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.89 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.88 | 19638242 18665156 18522880 18407596 20032147 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.88 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
2.51 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.51 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.21 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
4.21 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.77 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
14.77 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
14.77 | 20137499 19254457 21278145 19850985 19426721 19812893 19499222 20101389 12771043 20434301 19256749 18978307 12112319 15885732 18754104 20118626 19638242 2422723 9163691 20501860 19690152 20452335 21047994 18648771 16942905 15175105 19642983 19090486 21167192 18644402 21071580 19294768 2862719 18977376 19551842 20405173 19073162 10737359 20492335 19427195 20583210 19833225 19996281 19255062 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
14.77 | 19482888 21047994 19812893 8742319 15975961 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.77 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
19.57 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
19.57 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
19.57 | 18164116 18775883 18253720 18544905 3124819 19004024 18308698 16267830 16842330 17174075 18093689 17854601 9362446 2563599 17942915 18079962 18282651 19539802 19126423 21159647 19519916 19009564 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
19.57 | 17172636 1399818 18308698 2563599 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.57 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.47 | 8266340 19066396 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
9.83 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
9.83 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.49 | 20970405 21163286 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.49 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.49 | 11884234 19555203 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.32 | 10496685 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.67 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.00 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.00 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.61 | 9029167 3581430 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.46 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.33 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.33 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.33 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.56 | 17016548 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.41 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.41 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.84 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.31 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
11.76 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
11.76 | 18007984 18929643 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.51 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.51 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11118676 11896295 11222880 11399792 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.51 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.71 | 12752131 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.82 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.36 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.36 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
10.36 | 3137016 16876388 4039156 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.02 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.10 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.16 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.30 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.77 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.28 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.54 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
7.54 | 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.18 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.18 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.65 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.65 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.46 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.68 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |